Which has grown faster, LMAT or NVAX?

Over the past five years, NVAX grew revenue faster — LMAT at a 11.76% CAGR versus NVAX at 118.86%.

Does LMAT or NVAX pay a bigger dividend?

LMAT pays a dividend (1.17% yield), while NVAX has no payments in the available dividend history.

Is LMAT or NVAX more profitable?

LMAT runs the higher net margin — LMAT at 25.02% versus NVAX at -59.87%.

How have LMAT and NVAX total returns compared?

Over the past 10 years, LMAT delivered 16.21% and NVAX delivered -10.98% annualized total return. Past performance doesn't predict future results.

LeMaitre Vascular, Inc. (LMAT) vs Novavax, Inc. (NVAX)

A side-by-side comparison of LeMaitre Vascular, Inc. and Novavax, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LMAT

LeMaitre Vascular, Inc.

$1.81B

$79.05HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

NVAX

Novavax, Inc.

$1.86B

$11.32HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — LMAT vs NVAX

growth of $100 · dividends reinvested · last 10y

LMAT +349.0% (+16.2%/yr)NVAX -68.6% (-10.9%/yr)LMAT compounded faster over this window

Log scale — wide-divergence pair

LMAT NVAX

LMAT vs NVAX: by the numbers

•NVAX is the larger company ($1.86B vs $1.81B market cap).
•LMAT is profitable (25.02% net margin) while NVAX runs a net loss (-59.87%).
•NVAX grew revenue faster over the past five years (118.86% vs 11.76% CAGR).
•LMAT pays a dividend (1.17% yield), while NVAX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	LMAT	NVAX
P/E ratio	27.74	N/A
Forward P/E	27.52	N/A
PEG ratio	1.43	N/A
P/S ratio	6.88	4.50
P/B ratio	4.30	N/A
EV / EBITDA	21.67	N/A
FCF yield	4.09%	N/A

Profitability

Metric	LMAT	NVAX
Gross margin	72.90%	93.67%
Operating margin	29.46%	50.14%
Net margin	25.02%	-59.87%
ROE	15.62%	N/A
ROIC	9.81%	-36.37%

Dividends

Metric	LMAT	NVAX
Dividend yield	1.17%	N/A
Payout ratio	33.33%	N/A

Growth (annualized)

Metric	LMAT	NVAX
Revenue CAGR (5Y)	11.76%	118.86%
EPS CAGR (5Y)	19.42%	N/A
FCF CAGR (5Y)	13.06%	N/A
Total return CAGR (5Y)	9.79%	-40.61%

Frequently asked

Which has grown faster, LMAT or NVAX?: Over the past five years, NVAX grew revenue faster — LMAT at a 11.76% CAGR versus NVAX at 118.86%.
Does LMAT or NVAX pay a bigger dividend?: LMAT pays a dividend (1.17% yield), while NVAX has no payments in the available dividend history.
Is LMAT or NVAX more profitable?: LMAT runs the higher net margin — LMAT at 25.02% versus NVAX at -59.87%.
How have LMAT and NVAX total returns compared?: Over the past 10 years, LMAT delivered 16.21% and NVAX delivered -10.98% annualized total return. Past performance doesn't predict future results.

Go deeper

Full LMAT analysis Full NVAX analysis Interactive comparison tool

Dig into the metrics

LeMaitre Vascular P/E ratio LeMaitre Vascular dividend yield LeMaitre Vascular ROE Novavax ROE LeMaitre Vascular operating margin Novavax operating margin LeMaitre Vascular revenue growth Novavax revenue growth LeMaitre Vascular free cash flow Novavax free cash flow

LeMaitre Vascular & Novavax appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.